Search

In 2012, the first National Plan to Address Alzheimer's Disease in the United States (U.S.) was released, a component of the National Alzheimer's Project Act legislation. Since that time, there have been incremental increases in U.S. federal funding for Alzheimer's disease and related dementia research, particularly in the areas of biomarker discovery, genetic link and related biological underpinnings, and prevention studies for Alzheimer's. A central theme in each of these areas has been the emphasis of cross-sector collaboration and private–public partnerships between government, non-profit organizations and for-profit organizations. This paper will highlight multiple private–public partnerships supporting the advancement of Alzheimer's research in the context of the National Plan to Address Alzheimer's. [ABSTRACT FROM AUTHOR]

Abstract: Alzheimer’s disease is recognized as a public health crisis worldwide. As public and private funding agencies around the world enhance and expand their support of Alzheimer’s disease research, there is an urgent need to coordinate funding strategies and leverage resources to maximize the impact on public health and avoid duplication of effort and inefficiency. Such coordination requires a comprehensive assessment of the current landscape of Alzheimer’s disease research in the United States and internationally. To this end, the National Institute on Aging at the National Institutes of Health and the Alzheimer’s Association developed the Common Alzheimer’s Disease Research Ontology (CADRO) as a dynamic portfolio analysis tool that can be used by funding agencies worldwide for strategic planning and coordination. [Copyright &y& Elsevier]